Sign in

Rukia Baruti Dames

Director at Burford Capital
Board

About Rukia Baruti Dames

Dr. Rukia Baruti Dames, 56, is an independent non‑executive director of Burford Capital Limited, serving since August 2022, with committee roles on the Compensation Committee and the Nominating & Corporate Governance Committee; she is a qualified solicitor (England & Wales) and a full‑time international arbitrator with advanced degrees from Birkbeck College (BA), University of Westminster (MA), and University of Geneva (PhD). Her governance credentials emphasize arbitration and litigation expertise, legal advisory, and nonprofit governance, supporting board effectiveness in a legally complex business.

Past Roles

OrganizationRoleTenureCommittees/Impact
SJ Berwin LLP (later King & Wood Mallesons)International arbitration & litigation practitioner2006–2010Practiced arbitration/litigation in leading City firm environments, foundational to governance oversight of legal risk.
Africa International Legal Awareness (AILA)Founder; Managing Director2011–2018Advanced African involvement in international legal community; nonprofit governance and stakeholder engagement.
African Arbitration AssociationCo‑founder; Secretary General2018–2022Promoted African arbitration practitioners; network building and standards development.
City of London commercial law practiceSolicitor1997–2006Early legal career; commercial law experience in major legal market.

External Roles

OrganizationRoleTenureCommittees/Impact
Tanzania International Arbitration CentreAdvisory Board Member2023–presentAdvisory contribution to arbitration institution; regional governance insights.

Board Governance

  • Independence: Board determined all non‑CEO directors (including Dr. Dames) are independent under SEC and NYSE rules.
  • Committees: Member, Compensation Committee (2 meetings in 2024); Member, Nominating & Corporate Governance Committee (2 meetings in 2024).
  • Board attendance: Board held four quarterly in‑person meetings in 2024; all directors attended (Chair attended one via teleconference), implying 100% attendance for Dr. Dames.
  • Executive sessions: Independent director executive sessions occur at each quarterly board meeting.
  • Tenure and refresh: Tenure ~2.5 years; board maintains diversity targets (≥30% women; currently ~33%).

Fixed Compensation

Component (FY2024)Amount (USD)Notes
Annual cash retainer$90,000Standard non‑executive director cash fees.
Committee membership feesNot disclosedNo separate membership fees disclosed beyond chair supplements.
Chair/vice chair supplements$0Not a chair or vice chair; chair/vice chair supplements apply to others only.
Meeting feesNot disclosedNo meeting fees disclosed.
Total cash fees$90,000FY2024 fees earned/paid in cash.

Performance Compensation

Equity ElementGrant DateValue (USD)InstrumentVesting/Restrictions
Annual director equity grant (NED Plan)June 4, 2024$35,000Restricted ordinary sharesTransfer/sale restricted until earlier of 3rd anniversary or end of board service.
Performance MetricDesignThresholdTargetOutcome
None (Director equity is time‑based, not performance‑based)N/AN/AN/AN/A; NED Plan grants are restricted shares without performance conditions.

Other Directorships & Interlocks

CategoryDetails
Current public company boardsNone disclosed.
Private/nonprofit/academic boardsAdvisory Board Member, Tanzania International Arbitration Centre (since 2023).
Committee roles elsewhereNot disclosed beyond advisory role.
Interlocks with BUR competitors/suppliers/customersNone disclosed.

Expertise & Qualifications

  • Qualified solicitor in England & Wales; full‑time independent arbitrator, with deep international arbitration and litigation background.
  • Founder/leader in legal nonprofits (AILA; African Arbitration Association), indicating stakeholder engagement and governance acumen.
  • Advanced academic credentials (BA, MA, PhD) underpin analytical rigor relevant to Burford’s complex legal finance activities.

Equity Ownership

ItemDetail
NED Plan shares held as of Dec 31, 20244,959 ordinary shares (restricted).
Director stock ownership guidelineMinimum 4× base annual cash retainer; includes both vested and unvested restricted shares/RSUs; 5‑year window to achieve threshold.
Hedging/pledgingProhibited for directors; anti‑hedging, anti‑pledging, margin restrictions in Insider Trading Policy.
Compliance status vs guidelineNot individually disclosed.

Potential Conflicts & Related‑Party Exposure

  • Related‑party transactions: Audit Committee oversees policy; none disclosed involving non‑executive directors (other than former director Hugh Steven Wilson) in FY2024.
  • Commitments to BUR private funds: None for non‑executive directors in 2024 (excluding former director Wilson).
  • Holdings of BUR debt securities: Not disclosed for Dr. Dames; specific holdings noted only for Chair and two executives.
  • Anti‑conflict governance: Independence monitoring and resignation process if conflicts arise; annual independence determinations.

Governance Assessment

  • Strengths: Independent status; active roles on compensation and nominating/governance committees; full board attendance in 2024; robust anti‑hedging/pledging policy; board executive sessions each quarter.
  • Alignment: Director equity via time‑based restricted shares and meaningful ownership guidelines (4× retainer, 5‑year window) encourage skin‑in‑the‑game.
  • Red flags: No personal related‑party transactions, fund commitments, or debt holdings disclosed; no overboarding issues flagged.
  • Implications for investors: Legal/arbitration expertise strengthens oversight of case selection, enforcement, and risk; committee participation supports pay governance and board refreshment; absence of conflicts and strong attendance bolster investor confidence in board effectiveness.